Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
This rapid clearance contributes to the favorable safety profile, as the compound itself does not accumulate in tissues
Acute respiratory distress syndrome (ARDS) is considered as a decisive cause of death in COVID-19 disease (Gralinski and Baric, 2015
At high doses, the chemical can also raise blood pressure or cause heart problems
Component recovery, stability, and chromatographic resolution in a blend
Results continue building with additional cycles
Option (Evidence Strength: Grade C) One randomized trial with an oral PPS group for comparison reported that CyA (3 mg/ kg/day divided into two doses) resulted in 75% of patients experiencing clinically significant improvement compared to 19% of a PPS comparison group after six months of treatment
